Suchergebnisse - "Parker, Matthew J S"

PubPharm (12)

1

Nailfold capillaroscopy by smartphone-dermatoscope for connective tissue disease diagnosis in interstitial lung disease : a prospective observational study

enthalten in: ERJ open research | 2021

von Jee, A. | Parker, M. | McGill, N. | +4

2

Diagnosis of myositis-associated interstitial lung disease : Utility of the myositis autoantibody line immunoassay

enthalten in: Respiratory medicine | 2021

von Jee, A. | Parker, M. | Bleasel, J. | +7

3

Focal hamstring muscle oedema and atrophy post-anterior cruciate ligament reconstruction mimicking focal myositis

enthalten in: Rheumatology (Oxford, England) | 2021

von Sheikh, A. | Parker, M. | Gilbert, R. | +1

4

Baseline Characteristics and Survival of an Australian Interstitial Pneumonia with Autoimmune Features Cohort

enthalten in: Respiration; international review of thoracic diseases | 2021

von Jee, A. | Parker, M. | Bleasel, J. | +7

5

Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand : A position statement from the Thoracic Society of Australia and New Zealand

enthalten in: Respirology (Carlton, Vic.) | 2021

von Jee, A. | Sheehy, R. | Hopkins, P. | +21

6

Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand : A position statement from the Thoracic Society of Australia and New Zealand*

enthalten in: Respirology | 2021

von Jee, A. | Sheehy, R. | Hopkins, P. | +21

7

First risk, next reward? A new clinico-radiological risk model predicts mortality in rheumatoid arthritis-associated interstitial lung disease

enthalten in: Respirology (Carlton, Vic.) | 2020

von Parker, M. | Corte, T.

CommentOn: Respirology. 2020 Dec;25(12):1257-1264. - PMID 32441061

8

First risk, next reward? A new clinico‐radiological risk model predicts mortality in rheumatoid arthritis‐associated interstitial lung disease

enthalten in: Respirology | 2020

von Parker, M. | Corte, T.

9

Including myositis-specific autoantibodies improves performance of the idiopathic inflammatory myopathies classification criteria

enthalten in: Rheumatology (Oxford, England) | 2019

von To, F. | Parker, M. | Ventín-Rodríguez, C. | +2

10

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort

enthalten in: Rheumatology (Oxford, England) | 2019

von Parker, M. | Oldroyd, A. | Roberts, M. | +6